Hanx Biopharmaceuticals chairman Dr Faming Zhang said: "We are thrilled to see the first patient entered into a clinical ...

Biotechnology, which uses living systems and organisms to develop new products, is transforming healthcare in incredible ways ...

The St. Louis-born biopharmaceutical company has a new life and new focus, four months after its board sought to dissolve the ...

Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

Anbio Biotechnology seeks IPO funding to expand in the IVD market. Discover why NNNN stock’s potential is tempered by ...

NEW YORK – Anbio Biotechnology filed this week a preliminary prospectus for an initial public offering on the Nasdaq exchange of 1.6 million shares at an anticipated offering price in the range of $5 ...

Shares of Puma Biotechnology, Inc. PBYI have rallied 24% in the past three months against the industry’s decline of 9.7%. The ...

Anbio Biotechnology filed for a 1.6 million-share initial public offering with the Securities and Exchange Commission. The company said Tuesday it expects the IPO to price between $5 and $6 per share, ...

Venture capital investors poured billions into the spine surgery industry from 2000 to 2023, according to a study in the January 2025 issue of The Spine Journal ...

The lungs are a tempting place for cancer cells -- so much so that more than half of people with advanced cancer elsewh ...

Achieving biotech sovereignty will reduce dependency on foreign nations for critical products and technologies, ensuring ...

The year 2025 will witness India assuming critical role in the global biotechnology revolution, and the first Bio-E3 policy ...